Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:DG O-32:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003769 AN006189 Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease Brain Human Alzheimers disease University of Melbourne LC-MS
ST003678 AN006039 The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST002713 AN004398 Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics Cultured cells Human Cancer University of Colorado Denver LC-MS
ST002522 AN004155 Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice Liver Mouse Oxidative stress University of Science and Technology of China LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST001272 AN002112 Growth cone memebrane and growth cone particulate lipidomics Brain Mouse Eye disease University of Miami LC-MS
ST001105 AN001798 Retinal ganglion cells lipid profiling Eye tissue Mouse Eye disease University of Miami LC-MS
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
  logo